<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Guidelines for surgical treatment of gastroesophageal reflux disease.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Guidelines for surgical treatment of gastroesophageal reflux disease. Los Angeles (CA): Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); 2010 Feb. 46 p.  [293 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Guidelines for surgical treatment of gastroesophageal reflux disease (GERD). Santa Monica (CA): Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); 2001 Jun. 6 p. [39 references]&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Barium swallow  (87.61); Barrett's esophagus  (530.85); Chest pain, unspecified  (786.50); Congenital hiatus hernia  (750.6); Cough  (786.2); Dysphagia, unspecified  (787.20); Esophageal manometry  (89.32); Esophageal reflux  (530.81); Esophagectomy, not otherwise specified  (42.40); Esophagitis, unspecified  (530.10); Laparoscopic robotic assisted procedure  (17.42); Laparoscopy  (54.21); Morbid obesity  (278.01); Stricture and stenosis of esophagus  (530.3)"/><FieldValue Value="MSH: Asthma ; Barrett Esophagus ; Biopsy ; Carcinoma ; Chest Pain ; Constriction, Pathologic ; Cough ; Deglutition Disorders ; Digestive System Surgical Procedures ; Dilatation ; Esophageal pH Monitoring ; Esophageal Stenosis ; Esophagectomy ; Esophagitis ; Fundoplication ; Gastroesophageal Reflux ; Hoarseness ; Laparoscopes ; Laparoscopy ; Obesity, Morbid ; Outcome Assessment (Health Care) ; Patient Satisfaction ; Quality of Life ; Risk Assessment "/><FieldValue Value="MTH: Asthma ; Barium swallow ; Barrett Esophagus ; Biopsy ; Carcinoma ; Chest Pain ; Client satisfaction ; Coughing ; Deglutition Disorders ; Dilatation - action ; Esophageal motility study ; Esophageal Stenosis ; Esophagitis ; Esophagogastric fundoplasty ; Esophagogastroduodenoscopy ; Gastroesophageal reflux disease ; Hoarseness ; Laparoscopy ; Pulmonary aspiration ; Quality of life ; Risk Assessment ; Robotic Surgical Systems ; Severe dysplasia ; Stenosis "/><FieldValue Value="PDQ: Barrett's esophagus ; biopsies ; dysphagia ; laparoscopy "/><FieldValue Value="SNOMEDCT_US: Asthma  (195967001); Barium swallow  (168821007); Barrett's esophagus  (302914006); Biopsy  (129314006); Biopsy  (86273004); Carcinoma  (68453008); Chest pain  (29857009); Client satisfaction  (406193000); Congenital hiatus hernia  (47028006); Cough  (263731006); Cough  (272039006); Cough  (49727002); Difficulty swallowing  (288939007); Difficulty swallowing  (40739000); Dilation - action  (129419002); Esophageal dilator  (705488007); Esophageal manometer  (463797005); Esophageal manometry  (20816008); Esophageal motility study  (86543007); Esophagectomy  (45900003); Esophagitis  (16761005); Esophagogastric fundoplasty  (359887003); Esophagogastric fundoplasty  (359890009); Esophagogastric fundoplasty  (359893006); Esophagogastric fundoplasty  (48835001); Esophagogastroduodenoscopy  (387596007); Esophagogastroduodenoscopy  (76009000); Esophagus acid reflux test with intraluminal pH electrode  (70815009); Gastroesophageal reflux disease  (235595009); Gastroesophageal reflux disease  (698065002); Hoarse  (50219008); Laparoscope  (86174004); Laparoscopy  (108191006); Laparoscopy  (73632009); Monitoring of esophageal impedance  (442079009); Morbid obesity  (238136002); Operative procedure on digestive system  (107907001); Partial fundoplication  (235187003); Peptic stricture of esophagus  (235596005); Peristaltic contraction of esophagus  (68281000); Pulmonary aspiration  (68052005); Risk assessment  (225338004); Robotic surgical system  (466893009); Severe dysplasia  (55237006); Stricture  (27551008); Stricture of esophagus  (63305008)"/><FieldValue Value="SPN: DILATOR, ESOPHAGEAL ; PERITONEOSCOPE "/><FieldValue Value="UMD: Catheters, Esophageal, pH Monitoring  (18-735); Dilators, Esophageal  (11-257); Laparoscopes  (12-291); Manometers, Gastrointestinal Tract, Esophagus  (13-108)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Gastroesophageal reflux disease (GERD), including Barrett's esophagus and peptic stricture&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Diagnosis" /><FieldValue Value="Evaluation" /><FieldValue Value="Management" /><FieldValue Value="Risk Assessment" /><FieldValue Value="Treatment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Gastroenterology" /><FieldValue Value="Surgery" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Physicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To assist physicians and patient decisions about the appropriate use of laparoscopic surgery for gastroesophageal reflux disease (GERD)&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Individuals with documented gastroesophageal reflux disease (GERD)&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Diagnosis/Evaluation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Flexible esophagoscopy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Histologic confirmation and staging of Barrett's esophagus &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;24-Hour pH&amp;ndash;metry &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Multichannel intraluminal esophageal impedance (insufficient evidence for a recommendation) &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Treatment/Management&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Preoperative work-up (esophagogastroduodenoscopy [EGD], esophageal manometry, barium swallow) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Medical versus surgical treatment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Surgical technique and training &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Laparoscopic versus open treatment of GERD &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Partial versus total fundoplication &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Anterior or Toupet versus Nissen fundoplication &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Anterior versus Toupet fundoplication &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Short gastric vessel division &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Crural closure &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Robotic surgery &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Antireflux surgery in the morbidly obese patient &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Esophageal dilators &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Outcome risk assessment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Revisional surgery for failed antireflux procedures &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Outcomes assessment (including patient quality of life and satisfaction with surgery) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Surveillance of Barrett's esophagus after antireflux surgery &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Quality of life &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Satisfaction with surgery &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Symptomatic relief &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Postoperative complications &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Primary Sources)" /><FieldValue Value="Hand-searches of Published Literature (Secondary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A systematic literature search was performed on MEDLINE in March 2008. The search strategy was limited to adult English language articles and is shown in Figure 1 in the original guideline document. The guideline developer identified 448 relevant articles. The abstracts were reviewed by four committee members and divided into the following categories:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Randomized studies, metaanalysis, and systematic reviews &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Prospective studies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Retrospective studies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Case reports &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Review articles &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Randomized controlled trials, metaanalysis, and systematic reviews were selected for further review along with prospective and retrospective studies that included at least 50 patients. Studies with smaller samples were considered when additional evidence was lacking. The most recent reviews were also included. All case reports, older reviews, and smaller studies were excluded. According to these exclusion criteria, 227 articles were reviewed. Whenever the available evidence from Level I studies (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field) was considered to be adequate, lower evidence level studies were not considered. A review of the available evidence on endoluminal treatment of gastroesophageal reflux disease (GERD) has recently been published by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) in April 2009.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The reviewers graded the level of evidence and manually searched the bibliography of each article for additional articles that may have been missed during the original search. The additional relevant articles (n=66) found were also included in the review.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A total of 293 graded articles relevant to this guideline were reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level I&lt;/strong&gt;: Evidence from properly conducted randomized, controlled trials&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level II&lt;/strong&gt;: Evidence from controlled trials without randomization; cohort or case-control studies; multiple time series; dramatic uncontrolled experiments&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level III&lt;/strong&gt;: Descriptive case series; opinions of expert panels&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To facilitate review by multiple reviewers, these articles were divided into the following topics:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Fundoplication versus medical treatment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Laparoscopic versus open fundoplication &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Partial versus full fundoplication or partial versus partial &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Other technique &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Revisions &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Outcome &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Predictors of success &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Other articles &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The recommendations included in this guideline were devised based on the reviewers' grading of all articles (see &quot;Rating Scheme for the Strength of the Evidence&quot;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The recommendations were explicitly linked to the supporting evidence. The strengths and weaknesses of the available evidence were highlighted and expert opinion was sought where the evidence was lacking.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Grades of Recommendation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grade A&lt;/strong&gt;: Based on high level (Level I or II), well-performed studies with uniform interpretation and conclusions by the expert panels&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grade B&lt;/strong&gt;: Based on high level, well-performed studies with varying interpretations and conclusions by the expert panels&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grade C&lt;/strong&gt;: Based on lower level evidence (Level II or less) with inconsistent findings and/or varying interpretations or conclusions by the expert panels&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;There has been one randomized controlled trial evaluating cost between medical (omeprazole) and surgical therapy (open total and partial fundoplication) over a 5-year period. The study reported that total treatment costs in the medical group were significantly lower than for antireflux surgery in three European countries (Denmark, Norway, and Sweden) and higher in one (Finland) (level I*). One modeling study found that the cost equivalency point for medical and surgical therapy was at 10 years, whereas another still reported lower cost with medical therapy at 10 years (level III).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For surgery to compete with medical treatment, it has to be associated with minimal morbidity and cost.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The use of robotic surgery has been reported to be safe and feasible with similar outcomes during up to 1 year follow-up compared with laparoscopic antireflux surgery (level I-II). Most of the five available randomized controlled trials have reported a significant increase in operating times and cost when the robot is used (level I). Unfortunately, there are no clinical data comparing ergonomics and surgeon workload between these two approaches; however, level I data from simulator studies have shown less surgeon workload with the use of the robot.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Cost-utility studies show that ablative therapy is the preferred strategy over surveillance alone (all grades) and esophagectomy (high-grade intraepithelial neoplasia [HGIN]).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Antireflux surgery may be performed in a patient with non-neoplastic intestinal metaplasia (IM), indefinite for neoplasia (IND) and low-grade intraepithelial neoplasia (LGIN); with or without endoscopic therapy to eradicate the Barrett's tissue. Specifically, radiofrequency ablation (RFA) has been shown to be safe, clinically effective, and cost-effective in these disease states and may be performed in eligible patients before, during, or after anti-reflux surgery (Grade B).&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*See the &quot;Rating Scheme for the Strength of the Evidence&quot; field for definitions of the levels of evidence (I-III) and the &quot;Rating Scheme for the Strength of the Recommendations&quot; field for the grades of recommendations (A-C).&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;These guidelines are developed under the auspices of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), the guidelines committee and approved by the Board of Governors. The recommendations of each guideline undergo multidisciplinary review and are considered valid at the time of production based on the data available.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline was reviewed and approved by the Board of Governors of SAGES, February 2010.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Definitions of the levels of evidence (&lt;strong&gt;I-III&lt;/strong&gt;) and the grades of the recommendations (&lt;strong&gt;A-C&lt;/strong&gt;) are provided at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Diagnosis&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Based on the available evidence, the diagnosis of gastroesophageal reflux disease (GERD) can be confirmed if at least one of the following conditions exists: a mucosal break seen on endoscopy in a patient with typical symptoms, Barrett's esophagus on biopsy, a peptic stricture in the absence of malignancy, or positive pH&amp;ndash;metry (&lt;strong&gt;Grade A&lt;/strong&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A newer test to objectively document gastroesophageal reflux is multichannel intraluminal esophageal impedance but the available evidence is insufficient to provide firm recommendations.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Medical versus Surgical Treatment&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Surgical therapy for GERD is an equally effective alternative to medical therapy and should be offered to appropriately selected patients by appropriately skilled surgeons (&lt;strong&gt;Grade A&lt;/strong&gt;). Surgical therapy effectively addresses the mechanical issues associated with the disease and results in long-term patient satisfaction (&lt;strong&gt;Grade A&lt;/strong&gt;). For surgery to compete with medical treatment, it has to be associated with minimal morbidity and cost.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Surgical Technique, Learning Curves, and Their Influence on Outcome&lt;/span&gt;&lt;/strong&gt; &lt;/p&gt;&#xD;&#xA;&lt;p&gt;The standardization of antireflux surgery technique is highly desirable, as it has been shown to lead to good postoperative patient outcomes (&lt;strong&gt;Grade A&lt;/strong&gt;). Like any other surgical procedure, laparoscopic antireflux surgery is subject to a learning curve, which may impact patient outcomes. Therefore, surgeons with little experience in advanced laparoscopic techniques and fundoplication in particular should have expert supervision during their early experience with the procedure to minimize morbidity and improve patient outcomes (&lt;strong&gt;Grade B&lt;/strong&gt;). On the other hand, reoperative antireflux surgery should be performed in a high-volume center by an experienced foregut surgeon (&lt;strong&gt;Grade B&lt;/strong&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Laparoscopic versus Open Treatment of GERD&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Based on the available evidence that is of high quality (&lt;strong&gt;Level I&lt;/strong&gt;), laparoscopic fundoplication should be preferred over its open alternative as it is associated with superior early outcomes (shorter hospital stay and return to normal activities, and fewer complications) and no significant differences in late outcomes (failure rates) (&lt;strong&gt;Grade A&lt;/strong&gt;). Nevertheless, antireflux surgeons should be aware that laparoscopic fundoplication takes longer to perform and has a higher incidence of reoperations at least in the short term (&lt;strong&gt;Grade A&lt;/strong&gt;). Further study is needed to identify ways to minimize the incidence of reoperations after laparoscopic fundoplication.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Partial versus Total Fundoplication&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Anterior versus Nissen Fundoplication, Toupet versus Nissen Fundoplication, Anterior versus Toupet Fundoplication&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Based on the available evidence that is of high quality (&lt;strong&gt;Level I&lt;/strong&gt;), partial fundoplication is associated with less postoperative dysphagia, fewer reoperations, and similar patient satisfaction and effectiveness in controlling GERD compared with total fundoplication up to five years after surgery (&lt;strong&gt;Grade A&lt;/strong&gt;). Furthermore, a tailored approach to esophageal motility appears unwarranted (&lt;strong&gt;Grade B&lt;/strong&gt;). Nevertheless, the paucity of long-term follow-up data that compare the effectiveness of the procedures makes it hard to recommend one type of fundoplication over the other especially in an era where the long-term effectiveness of surgical treatment for GERD is questioned. It should also be noted that a body of literature suggests that anterior partial fundoplication may be less effective in the long term (&lt;strong&gt;Grade B&lt;/strong&gt;) and retrospective data suggests that partial fundoplication may not be as effective as total in the long run (&lt;strong&gt;Grade C&lt;/strong&gt;). Nonetheless, the evidence suggests that surgeons appropriately trained in minimally invasive techniques that perform surgery for GERD may minimize postoperative dysphagia by choosing a partial fundoplication (&lt;strong&gt;Grade A&lt;/strong&gt;) or a short total fundoplication (1 to 2 cm) over a large bougie (56 French) (&lt;strong&gt;Grade C&lt;/strong&gt;) and maximize the effectiveness of the procedure by choosing a total fundoplication (&lt;strong&gt;Grade C&lt;/strong&gt;) or a longer (at least 3 cm) posterior fundoplication (&lt;strong&gt;Grade C&lt;/strong&gt;). It should also be noted that there are regional differences in expert opinion and practice in the choice of fundoplication type for GERD with most North American experts choosing a total fundoplication due to concerns for the long term effectiveness of the procedure. Controlled studies that take into account these guidelines are needed.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Other Technical Aspects That May Influence Outcome&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Short Gastric Vessel Division&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;When the fundus can be wrapped around the esophagus without significant tension, no division of the short gastrics seems necessary (&lt;strong&gt;Grade A&lt;/strong&gt;). Division should be undertaken when a tension-free fundoplication cannot be accomplished (&lt;strong&gt;Grade B&lt;/strong&gt;). It should also be noted that expert opinion in North America advocates for the routine division of the short gastric vessels to minimize tension (&lt;strong&gt;Grade C&lt;/strong&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Crural Closure&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Crural closure should be strongly considered during fundoplication when the hiatal opening is large and mesh reinforcement may be beneficial in decreasing the incidence of wrap herniation (&lt;strong&gt;Grade B&lt;/strong&gt;). Anterior crural closure may be associated with less postoperative dysphagia, but additional evidence is needed to provide a firm recommendation (&lt;strong&gt;Grade C&lt;/strong&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Use of Robotic Surgery&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;While robotic assistance can be safely and effectively used for fundoplication, its higher cost compared with conventional laparoscopy and similar short-term patient outcomes make it a less than ideal initial choice (&lt;strong&gt;Grade B&lt;/strong&gt;). Nevertheless, further study regarding learning curves and surgeon workload with the robotic technique are needed before stronger recommendations can be made.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Antireflux Surgery in the Morbidly Obese Patient&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Due to concerns for higher failure rates after fundoplication in the morbidly obese patient (body mass index [BMI] &amp;gt;35 kg/m&lt;sup&gt;2&lt;/sup&gt;) and the inability of fundoplication to address the underlying problem (obesity) and its associated comorbidities, gastric bypass should be the procedure of choice when treating GERD in this patient group (&lt;strong&gt;Grade B&lt;/strong&gt;). The benefits in patients with BMI &amp;gt;30 is less clear and needs further study.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Use of Esophageal Dilators&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The placement of an esophageal dilator during the creation of laparoscopic fundoplication is advisable as it leads to decreased postoperative dysphagia but should be weighed against a small risk of esophageal injury (&lt;strong&gt;Grade B&lt;/strong&gt;). A 56-French bougie has been found to be effective but the evidence is limited (&lt;strong&gt;Grade C&lt;/strong&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Predictors of Success&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Preoperative Patient Compliance with Antireflux Medications, Age, Postoperative &quot;Diaphragmatic Stressors&quot;, Psychological Disease and Intervention, Atypical Symptoms, Esophageal Function, Patterns of Reflux, Response to Preoperative Proton Pump Inhibitor (PPI), Preoperative Gastric Emptying&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Surgeons should be aware that fundoplication in patients demonstrating poor compliance with PPI therapy preoperatively or with poor response to preoperative PPI treatment is associated with poorer outcomes (&lt;strong&gt;Grade C&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Age should not be considered a contraindication for antireflux surgery in otherwise acceptable operative candidates, as outcomes in this patient group are similar to outcomes of younger patients (&lt;strong&gt;Grade C&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Care should be taken to minimize early postoperative severe gagging, belching, and vomiting as weak evidence suggests that they may lead to anatomical failure of fundoplication (&lt;strong&gt;Grade C&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A partial wrap should be considered in patients with a preoperative diagnosis of major depression, as it may lead to better postfundoplication outcomes in this patient group that tends to have generally inferior outcomes (&lt;strong&gt;Grade C&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Revisional Surgery for Failed Antireflux Procedures&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Laparoscopic reoperative antireflux surgery is feasible, safe, and effective but has higher complication rates compared with primary repair and should be undertaken only by experienced surgeons using a similar approach to primary fundoplication (&lt;strong&gt;Grade B&lt;/strong&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Outcomes&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Response of Typical GERD Symptoms to Antireflux Surgery, Response of Atypical Reflux Symptoms to Antireflux Surgery, Objective Outcomes, Postoperative Complications, Postoperative Use of Acid Reducing Medications, Quality of Life and Satisfaction with Surgery&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Laparoscopic antireflux surgery is effective at restoring the mechanical barrier to reflux with significant improvements in the lower esophageal sphincter (LES) pressure and acid reflux exposure, can be performed safely with minimal perioperative morbidity and mortality, and leads to high patient satisfaction rates and improved quality of life (&lt;strong&gt;Grade A&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Laparoscopic antireflux surgery is an effective treatment strategy for typical symptoms of GERD with significant improvements in rates of dysphagia, heartburn, and regurgitation and should be considered in appropriately selected patients and be performed by appropriately trained surgeons (&lt;strong&gt;Grade A&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;While atypical symptoms improve in a majority of patients after antireflux surgery, symptom persistence is higher compared with patients with typical symptoms and surgeons should therefore carefully select and counsel these patients preoperatively (&lt;strong&gt;Grade B&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients undergoing laparoscopic antireflux surgery should be counseled preoperatively about the reported rates of symptom relapse and resumption of acid reducing medications (&lt;strong&gt;Grade A&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Barrett's Esophagus and Antireflux Surgery&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Preoperative Endoscopy, Histological Assessment of Barrett's, Impact of Histology Findings on Antireflux Surgery Candidacy and Timing of Surgery, Antireflux Surgery for Barrett's Esophagus, Surveillance of Barrett's Esophagus After Antireflux Surgery&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Detection of Barrett's esophagus with adenocarcinoma involving the submucosa or deeper excludes the patient from antireflux surgery and demands comprehensive stage-specific therapy (esophagectomy, chemotherapy, and/or radiation therapy) (&lt;strong&gt;Grade A&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;High-grade intraepithelial neoplasia (HGIN), and intramucosal carcinoma (IMC) can be effectively treated with endoscopic therapy including photodynamic therapy (PDT), endoscopic mucosal resection (EMR), and radiofrequency ablation (RFA), alone or in combination (&lt;strong&gt;Grade B&lt;/strong&gt;). Anti-reflux surgery can be performed after achieving complete histological eradication of the lesion with endoscopic therapy (&lt;strong&gt;Grade C&lt;/strong&gt;). Esophagectomy remains an option for HGIN and IMC, either as salvage in the case of endoscopic therapy failure or as primary therapy. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Antireflux surgery may be performed in a patient with non-neoplastic intestinal metaplasia (IM), indefinite for neoplasia (IND) and low-grade intraepithelial neoplasia (LGIN); with or without endoscopic therapy to eradicate the Barrett's tissue. Specifically, RFA has been shown to be safe, clinically effective, and cost-effective in these disease states and may be performed in eligible patients before, during, or after anti-reflux surgery (&lt;strong&gt;Grade B&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Antireflux surgery does not alter the need for continued surveillance endoscopy in patients with Barrett's esophagus. Patients who have undergone endoscopic ablative therapy and antireflux surgery should continue surveillance endoscopy according to their baseline grade of Barrett's (&lt;strong&gt;Grade A&lt;/strong&gt;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The available evidence is inconclusive about the resolution or improvement of Barrett's after antireflux surgery. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level I&lt;/strong&gt;: Evidence from properly conducted randomized, controlled trials&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level II&lt;/strong&gt;: Evidence from controlled trials without randomization; cohort or case-control studies; multiple time series; dramatic uncontrolled experiments&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level III&lt;/strong&gt;: Descriptive case series; opinions of expert panels&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grades of Recommendation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grade A&lt;/strong&gt;: Based on high level (Level I or II), well-performed studies with uniform interpretation and conclusions by the expert panels&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grade B&lt;/strong&gt;: Based on high level, well-performed studies with varying interpretations and conclusions by the expert panels&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grade C&lt;/strong&gt;: Based on lower level evidence (Level II or less) with inconsistent findings and/or varying interpretations or conclusions by the expert panels&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is specifically stated for each recommendation (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Appropriate use of surgical therapy for gastroesophageal reflux disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Relief of gastric reflux symptoms &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Improved quality of life &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Reduced postoperative complications &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Complications from surgery (e.g., postoperative dysphagia, gas bloat syndrome, esophagogastric perforations, pneumothorax, splenic injuries, vagal nerve injuries, infections, port-site hernias, and rarely death) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Requirement for reoperation &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="430" OrdBy="800" Name="Contraindications"><Field FieldID="144" OrdBy="805" ID="431" Name="Contraindications" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Esophageal manometry is frequently performed before surgery and advocated by many experts in order to identify conditions that might contraindicate fundoplication (such as achalasia) or modify the type of fundoplication according to a tailored approach based on esophageal motility.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Clinical practice guidelines are intended to indicate the best available approach to medical conditions as established by a systematic review of available data and expert opinion. The approach suggested may not necessarily be the only acceptable approach given the complexity of the healthcare environment. These guidelines are intended to be flexible, as the surgeon must always choose the approach best suited to the patient and to the variables at the moment of decision. These guidelines are applicable to all physicians who are appropriately credentialed regardless of specialty and address the clinical situation in question. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Despite the availability of several randomized controlled trials and metaanalyses, most available studies are either prospective or retrospective reports. Several limitations exist in the examined literature. First, the general methodological quality of the available trials is low due to small patient numbers, inadequate trial design or methodology, lack of standardization, and lack of objective outcome assessment. Only a few studies report a power analysis and define a main outcome variable. Thus, the validity of several of the pooled analyses of the available metaanalyses is hampered by statistically significant heterogeneity related to small sample sizes. In addition, the reporting of outcomes varies significantly as does the follow-up period making it difficult to combine and compare such data. Furthermore, there are several differences in the surgical technique used that may directly impact the outcomes of interest and introduce bias into the reported outcomes. Finally, the majority of the studies do not report details on the expertise of their surgeons, and most have been conducted in single institutions making the generalization of their findings difficult. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An implementation strategy was not provided.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Patient Resources" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /><FieldValue Value="Safety" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Guidelines for surgical treatment of gastroesophageal reflux disease. Los Angeles (CA): Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); 2010 Feb. 46 p.  [293 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="1998 Feb (revised 2010 Feb)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). No outside funding sources were used.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Guideline Committee&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Committee Members&lt;/em&gt;: Robert Fanelli, MD, &lt;em&gt;Chair&lt;/em&gt;; William Richardson, MD, &lt;em&gt;Co-Chair&lt;/em&gt;; Dimitrios Stefanidis, MD, PhD; William W. Hope, MD; Geoffrey P. Kohn, MD; Patrick R. Reardon, MD; E. Matt Ritter, MD; Keith Gersin, MD; Thom E. Lobe, MD; Keith Apelgren, MD; Ziad Awad, MD; L. Michael Brunt, MD; Ronald Clements, MD; David Earle, MD; David Edelman, MD; Timothy Farrell, MD; Erika Fellinger, MD; Stephen Haggerty, MD; Jeffrey Hazey, MD; Steven Heneghan, MD; Gregory Kahn, MD; James Korndorffer, MD; Henry Lujan, MD; Lisa Martin Hawver, MD; Sumeet Mittal, MD; Jonathan Myers, MD; David Overby, MD; Jonathan Pearl, MD; Raymond Price, MD; William Reed, MD; David Renton, MD; John Roth, MD; Alan Saber, MD; Julio Teixeria, MD; Andrew Wright, MD; Marc Zerey, MD&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Guidelines for surgical treatment of gastroesophageal reflux disease (GERD). Santa Monica (CA): Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); 2001 Jun. 6 p. [39 references]&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available from the &lt;a href=&quot;http://www.sages.org/publications/guidelines/guidelines-for-surgical-treatment-of-gastroesophageal-reflux-disease-gerd/&quot; title=&quot;SAGES Web site&quot;&gt;Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), 11300 West Olympic Blvd., Suite 600, Los Angeles, CA 90064. Web site: &lt;a href=&quot;http://www.sages.org&quot; title=&quot;SAGES Web site&quot;&gt;www.sages.org&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following is available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patient information for laparoscopic anti-reflux (GERD) surgery from SAGES. 2004 Feb. 5 p. Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.sages.org/pi_gerd.html&quot; title=&quot;SAGES Web site&quot;&gt;Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), 11300 West Olympic Blvd., Suite 600, Los Angeles, CA 90064 Web site: &lt;a href=&quot;http://www.sages.org&quot; title=&quot;SAGES Web site&quot;&gt;www.sages.org&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The printing of this brochure was made possible by a generous educational grant from U.S. Surgical Corporation.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This summary was completed by ECRI on November 19, 1999. The information was verified by the guideline developer on February 15, 2000. This summary was updated by ECRI on March 13, 2002. This summary was updated by ECRI Institute on August 10, 2010.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
